Results 31 to 40 of about 462,772 (320)

Long-Term Treatment of Postmenopausal Osteoporosis

Endocrinology and Metabolism, 2021
Osteoporosis is an incurable chronic condition, like heart disease, diabetes, or hypertension. A large gap currently exists in the primary prevention of fractures, and studies show that an estimated 80% to 90% of adults do not receive appropriate ...
Jacques P. Brown
semanticscholar   +1 more source

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis

Frontiers in Immunology, 2021
Osteoporosis is the most prevalent metabolic bone disease that affects half the women in the sixth and seventh decade of life. Osteoporosis is characterized by uncoupled bone resorption that leads to low bone mass, compromised microarchitecture and ...
Di Wu, Anna Cline-Smith, E. Shashkova, Ajit Perla, A. Katyal, R. Aurora   +5 more
semanticscholar   +1 more source

LncRNA-NEF is downregulated in postmenopausal osteoporosis and is related to course of treatment and recurrence

Journal of International Medical Research, 2019
Objectives We investigated the role of long non-coding (lnc) RNA-NEF (neighboring enhancer of FoxA2), a characterized oncogene in cancer biology, in postmenopausal osteoporosis and its diagnostic and prognostic value in this disease.
Xiaoyong Ma, Zhixue Guo, Wenshan Gao, Jianzhong Wang, Yong Liu, Fei Gao, Shaosong Sun, Xiaozhe Zhou, Zhaoyu Yang, Wenkui Zheng   +9 more
doaj   +1 more source

Impact of postmenopausal osteoporosis on the lives of Omani women and the use of cultural and religious practises to relieve pain: A hermeneutic phenomenological study

Health Expectations, 2023
Introduction Osteoporosis is a significant clinical and public health concern worldwide. Despite the impact of this condition on women's lives, most studies have focused on its clinical manifestations, drug efficacy, and medical treatment.
Faiza Al Zadjali, Jane Brooks, Terence W. O'Neill, Emma Stanmore   +3 more
doaj   +1 more source

Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials.

JAMA Internal Medicine, 2021
Importance The clinical decision to initiate bisphosphonate therapy for the treatment of osteoporosis requires balancing shorter-term harms and burdens (eg, gastroesophageal irritation or severe musculoskeletal pain) with longer-term benefits in reducing
W. Deardorff, I. Cenzer, Brian Nguyen, Sei J. Lee   +3 more
semanticscholar   +1 more source

Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis

International Journal of Endocrinology, 2013
Objective. To demonstrate the role of Wnt/β-catenin canonical pathway in postmenopausal osteoporosis by evaluating serum β-catenin levels in patients with postmenopausal osteoporosis and analyzing their possible relationship with serum OPG, RANKL, the ...
Xiao-Juan Xu, Lin Shen, Yan-Ping Yang, Rui Zhu, Bo Shuai, Cheng-Gang Li, Man-Xiang Wu   +6 more
doaj   +1 more source

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis

Journal of Orthopaedic Surgery and Research, 2021
Background Osteoporosis affects mostly postmenopausal women, leading to deterioration of the microarchitectural bone structure and low bone mass, with an increased fracture risk with associated disability, morbidity and mortality.
Filippo Migliorini, N. Maffulli, Giorgia Colarossi, J. Eschweiler, M. Tingart, M. Betsch   +5 more
semanticscholar   +1 more source

Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review

Journal of Orthopaedic Surgery and Research, 2021
Biochemical markers of bone turnover (BTMs), such as bone alkaline phosphatase (bALP), procollagen type I N propeptide (PINP), serum cross-linked C-telopeptides of type I collagen (bCTx), and urinary cross-linked N-telopeptides of type I collagen (NTx ...
Filippo Migliorini, N. Maffulli, F. Spiezia, M. Tingart, Peretti Giuseppe Maria, Giorgino Riccardo   +5 more
semanticscholar   +1 more source

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.

Endocrine Practice, 2020
Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the
Pauline M. Camacho, S. Petak, N. Binkley, Dima L. Diab, Leslie S. Eldeiry, A. Farooki, Steven T. Harris, Daniel L. Hurley, Jennifer J. Kelly, E. Lewiecki, Rachel Pessah-Pollack, M. McClung, Sunil J. Wimalawansa, Nelson B. Watts   +13 more
semanticscholar   +1 more source

The Impact of Practicing Exercise and Risk Factors Categorize in Osteoporotic Concerning Postmenopausal Women (Analytical study using binary logistic regression)

Diyala Journal of Medicine, 2023
Background: Osteoporosis is an illness that may be categorized as a "silent pandemic" because of its worldwide incidence. The essential characteristics of osteoporosis are bone mass reduction and degeneration in bone tissue's micro-architecture ...
Raed Farooq Khaleel ,, Abdulkaliq Abduljabbar Ali ,, Suhair Mohammed Hassoon   +2 more
doaj   +1 more source